Clinical Trial Update: Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment [NA]

View source ↗

Summary

Clinical trial update evaluating whether proteasome serves as a biomarker for hepatocellular carcinoma in cirrhotic patients after curative treatment; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Hepatocellular Carcinoma, Cirrhosis | NA | Status: UNKNOWN